Navigation Links
QIAGEN Acquires ESE GmbH
Date:1/12/2010

olutions. These include animal, food and environmental safety testing, where portability and the ability to be placed in diverse locations are key requirements perfectly addressed by the platform.

"We are excited about the addition of ESE's capabilities and technology portfolio. We believe it will considerably strengthen QIAGEN's portfolio of detection technologies and help us to better address the needs of our existing customers in a range of application fields. In addition, due to the unique features of ESE's technology, this transaction allows QIAGEN to synergistically apply our sample and assay technologies to the exciting, emerging point-of-need testing market segment," said Peer Schatz, QIAGEN's CEO. "QIAGEN has always been driving the dissemination of molecular biology. With this new technology portfolio, we now have the opportunity to shape a new dimension for molecular testing," Mr Schatz continued.

"The deal is a great fit for us," said Klaus Haberstroh, founder and CEO of ESE GmbH. "With its leadership in molecular sample and assay technologies, QIAGEN is the ideal partner to capitalize on our development and engineering know-how and to take our technology to the next level."

QIAGEN will establish ESE's development and manufacturing site in Stockach as a Center of Excellence in Detection Development and intends to retain and expand the employee base.

QIAGEN anticipates the one-time charges in connection with this acquisition not to exceed US$500,000 in 2010. The transaction is expected to contribute approximately US$6 million in sales in 2010. On an adjusted basis excluding one-time charges, integration and restructuring costs, and amortization of acquisition related intangible assets, the acquisition is expected to be neutral to EPS in 2010.

Abou
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
2. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
3. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) First Quarter 2008 Financial Results Call Set for May 6
4. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
5. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
6. WuXi AppTec and QIAGEN Enter into Partnership Agreement for Molecular Biomarker Development
7. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
8. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
9. U.S. Preventive Medicine Acquires Specialty Disease Management
10. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
11. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... ANDOVER, Mass. , Aug. ...  (NYSE: PHG ... at the  European Society of ... company is highlighting the full range of its cardiology solutions ... the care continuum from prevention and ...
(Date:8/28/2014)... Long, P.A.: , Do you, or did you, ... , Did you purchase your shares before September 10, 2013, ... , Did you lose money in your investment in Lannett ... rights? Rigrodsky & Long, P.A. , ... , announces that a complaint has been filed in the United ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces ... available in its catalogue: Needle-Free ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... technological and commercial prospects What does the ... Visiongain,s brand new report shows you the ...
Breaking Medicine Technology:Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
... Accuray Incorporated (Nasdaq: ... field of radiation oncology, today hosted a roundtable discussion ... is currently pending Congressional ratification. Offering the potential to ... the agreement, if ratified, promises important benefits to San ...
... (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: ... ALKS ) today announced additional results from a phase 2 ... which showed substantial improvements in glycemic control, including reductions in ... findings will be presented in a late breaking poster session ...
Cached Medicine Technology:Accuray Hosts Korean Embassy's Minister for Economic Affairs at Event to Support the U.S.-Korea Free Trade Agreement 2Accuray Hosts Korean Embassy's Minister for Economic Affairs at Event to Support the U.S.-Korea Free Trade Agreement 3Accuray Hosts Korean Embassy's Minister for Economic Affairs at Event to Support the U.S.-Korea Free Trade Agreement 4Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 2Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 3Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 4Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 5Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 6Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 7Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 8
(Date:8/29/2014)... August 30, 2014 Market Research ... 2009-2019 is a professional and in-depth market survey ... report firstly reviews the basic information of Glass ... The report then explores global and China’s top ... capacity, Production value, and market share etc. , ...
(Date:8/29/2014)... Healthpointe is proud to welcome to its ... be practicing out of Healthpointe’s newest office directly adjacent ... orthopedic team, Dr. Rodas is board-certified in ... occupational medicine. , Among Dr. Rodas’ many impressive ... Raytheon, the world-class defense and aerospace company. Additionally, Dr. ...
(Date:8/29/2014)... Dr. Parsa Mohebi M.D. has developed new ... achieve great results in hair transplantation. One of these ... an FUE method that harvests facial hair for transplanting to ... patients whose hair loss classification is 5 and above achieve ... great alternative for those advanced hair loss patients who may ...
(Date:8/29/2014)... California (PRWEB) August 29, 2014 ... to Chapman University Physical Therapy students via Clinical ... Chapman University will be shadowing Healthpointe providers and ... allow them to develop clinical experience and learn ... Therapy students will gain insight into several patient ...
(Date:8/29/2014)... (HealthDay News) -- Astronauts may be at heightened ... human immune systems, a new study suggests. That ... to asteroids, the moon and Mars undertaken in the ... space can be dangerous, NASA researchers say. They ... blood of International Space Station crew members remains relatively ...
Breaking Medicine News(10 mins):Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Dr. Anthony G. Rodas Joins Healthpointe Team at LAX Office 2Health News:Advanced Hair Loss Patients Can Now Qualify for Hair Transplants Using Facial Donor Hair 2Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2Health News:Spaceflight Might Weaken Astronauts' Immune Systems 2
... As part of its ongoing commitment to keeping ... recognized leader in innovative healthcare administration for over 20 ... new full-service pharmacy benefit management (PBM) program, MagnaCareRx. ... pharmacy benefit management. With costs rising, plan sponsors can,t ...
... findings , TUESDAY, July 7 (HealthDay News) -- Parents ... that show a reduced-dose schedule for the pneumococcal vaccine ... The current recommended dose schedule for 7-valent pneumococcal conjugate ... age of 6 months, followed by a booster vaccination ...
... linked in studies to lower incidence of type 2 diabetes ... of a protein created by fat cells are associated with ... protein, adiponectin, appears to have anti-inflammatory and insulin-sensitizing capabilities, according ... the Journal of the American Medical Association . , ...
... Ulrich Stroeher, Chairman of the Advisory,Board of Berlin Heart, today ... the company on 30 September 2009. , ... one of the,intellectual fathers of the successful ventricular assist device ... this area as,coordinator for projects with external cooperation partners. He ...
... , ATLANTA, July 7 Crawford Canada,s Bill Johnstone ... Company,s (NYSE: CRDA ; CRDB) Global Technical ... designed to more effectively coordinate and grow this market-leading ... is a major differentiator for Crawford worldwide in the ...
... ... ... roving weather star, Al Roker, has packed up his Penske truck once again to hit ... consecutive year, "Lend a Hand" continues its mission to help small charities across the country ...
Cached Medicine News:Health News:MagnaCare Answers Need for New Prescription Drug Program 2Health News:Fewer Shots Could Still Protect Kids From Pneumonia 2Health News:Fat-Cell Protein May Reduce Diabetes Risk 2Health News:Fat-Cell Protein May Reduce Diabetes Risk 3Health News:Berlin Heart Announces Restructuring of Management 2Health News:Bill Johnstone Named Senior Vice President of Crawford's Global Technical Services for the Americas 2Health News:Supergoop! Award-Winning SPF 30 Sunscreen & Skin Protection Lotion Featured On The Today Show 2
... VS1 is an easy to ... provides reliable, accurate, automated measurements ... designed to make your job ... bright, color-coded LED readings, proven ...
... (OLEH), an interactive electronic textbook, provides ... OLEH brings clinical decision support information ... right on the patient monitor screen ... and contributing to error reduction ...
... monitoring for flexible care settings., ... combine portability and measurement flexibility to ... of intermediate care environmentsat the patients ... heritage in patient monitoring, IntelliVue has ...
... The IntelliVue MP90 is designed to ... the highest acuity care environments. Built on ... IntelliVue MP90 with dual independent displays has ... measurements menu; built-in clinical support tools such ...
Medicine Products: